CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-17 | Freire Maria C Director | Grant or award | +2,370 | 6,815 | ||
| 2025-06-17 | Rowinsky Eric K Director | Grant or award | +2,370 | 24,339 | ||
| 2025-06-17 | SHERWIN STEPHEN A Director | Grant or award | +2,370 | 13,688 | ||
| 2025-06-17 | LANGER SUSAN Director | Grant or award | +2,370 | 5,129.1 | ||
| 2025-06-17 | DORSA CAROLINE Director | Grant or award | +3,160 | 31,002 | ||
| 2025-05-19 | Singhal Priya Head of Development | Sale 10b5-1 | −3,806 | $126.25 | $481K | 5,427.14 |
| 2025-05-02 | DORSA CAROLINE Director | Purchase | +1,235 | $122.72 | $152K | 27,842 |
| 2025-05-01 | Keeney Adam Head of Corporate Development | Option exercise | +938 | 2,838 | ||
| 2025-05-01 | Keeney Adam Head of Corporate Development | Shares withheld for taxes | −454 | $120.93 | $55K | 2,384 |
| 2025-05-01 | Keeney Adam Head of Corporate Development | Option exercise · Restricted Stock Unit | −938 | 939 | ||
| 2025-04-01 | Godbout Sean Chief Accounting Officer | Grant or award · Restricted Stock Unit | +545 | 545 | ||
| 2025-03-07 | SHERWIN STEPHEN A Director | Sale 10b5-1 | −8,760 | $150.02 | $1.3M | 11,318 |
| 2025-02-10 | Singhal Priya Head of Development | Option exercise | +1,212 | 9,423.48 | ||
| 2025-02-10 | Singhal Priya Head of Development | Shares withheld for taxes | −357 | $142.54 | $51K | 9,066.48 |
| 2025-02-10 | Singhal Priya Head of Development | Option exercise · Restricted Stock Unit | −1,212 | 0 | ||
| 2025-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +2,272 | 14,725.37 | ||
| 2025-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −670 | $142.54 | $96K | 14,055.37 |
| 2025-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −2,272 | 0 | ||
| 2025-02-10 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise | +3,257 | 25,712 | ||
| 2025-02-10 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Shares withheld for taxes | −1,371 | $142.54 | $195K | 24,341 |
Page 8 of 29 · 579 trades